Brookstone Capital Management Has Trimmed Ppl (PPL) Stake by $370,518; As Momenta Pharmaceuticals (MNTA) Share Value Declined, Opaleye Management Lifted by $900,000 Its Position

February 20, 2018 - By Marguerite Chambers

James A. Silverman increased its stake in Momenta Pharmaceuticals Inc (MNTA) by 11.11% based on its latest 2017Q3 regulatory filing with the SEC. Opaleye Management Inc bought 50,000 shares as the company’s stock declined 18.16% while stock markets rallied. The hedge fund run by James A. Silverman held 500,000 shares of the health care company at the end of 2017Q3, valued at $9.25M, up from 450,000 at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Momenta Pharmaceuticals Inc for a number of months, seems to be bullish on the $1.23 billion market cap company. The stock decreased 0.31% or $0.05 during the last trading session, reaching $16.05. About 523,711 shares traded. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has risen 54.42% since February 20, 2017 and is uptrending. It has outperformed by 37.72% the S&P500.

Brookstone Capital Management decreased its stake in Ppl Corp (PPL) by 5.82% based on its latest 2017Q3 regulatory filing with the SEC. Brookstone Capital Management sold 10,014 shares as the company’s stock rose 8.95% with the market. The institutional investor held 162,022 shares of the central company at the end of 2017Q3, valued at $6.15M, down from 172,036 at the end of the previous reported quarter. Brookstone Capital Management who had been investing in Ppl Corp for a number of months, seems to be less bullish one the $21.65 billion market cap company. The stock increased 1.13% or $0.35 during the last trading session, reaching $31.45. About 5.41 million shares traded. PPL Corporation (NYSE:PPL) has risen 2.43% since February 20, 2017 and is uptrending. It has underperformed by 14.27% the S&P500.

Brookstone Capital Management, which manages about $975.50M and $1.10 billion US Long portfolio, upped its stake in Ishares Tr (EMB) by 33,887 shares to 133,815 shares, valued at $15.58 million in 2017Q3, according to the filing. It also increased its holding in Ishares Tr (IVV) by 71,772 shares in the quarter, for a total of 242,138 shares, and has risen its stake in Ishares Tr (CIU).

Investors sentiment decreased to 1.1 in 2017 Q3. Its down 0.07, from 1.17 in 2017Q2. It is negative, as 37 investors sold PPL shares while 222 reduced holdings. 58 funds opened positions while 226 raised stakes. 479.53 million shares or 0.81% more from 475.65 million shares in 2017Q2 were reported. 5,913 are owned by Johnson Investment Counsel. Eqis Cap has invested 0.04% in PPL Corporation (NYSE:PPL). Rare Infra Limited reported 7,536 shares. Cantab Cap Prns Llp holds 0.02% of its portfolio in PPL Corporation (NYSE:PPL) for 3,148 shares. Tower Bridge Advsrs reported 7,806 shares or 0.03% of all its holdings. Chemung Canal Trust stated it has 0.05% in PPL Corporation (NYSE:PPL). Janney Management Llc has invested 0.02% in PPL Corporation (NYSE:PPL). Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 143,833 shares. Fred Alger Mgmt Inc has invested 0% in PPL Corporation (NYSE:PPL). Teacher Retirement Of Texas stated it has 0.21% of its portfolio in PPL Corporation (NYSE:PPL). Citigroup has invested 0.01% in PPL Corporation (NYSE:PPL). Whittier Com reported 0.01% in PPL Corporation (NYSE:PPL). Community Natl Bank Na holds 0.04% or 9,529 shares in its portfolio. Buckingham Asset Mngmt Ltd has invested 0.08% in PPL Corporation (NYSE:PPL). Raymond James Fincl Services Advsrs has 219,781 shares for 0.05% of their portfolio.

Among 14 analysts covering PPL Corporation (NYSE:PPL), 6 have Buy rating, 1 Sell and 7 Hold. Therefore 43% are positive. PPL Corporation had 40 analyst reports since August 5, 2015 according to SRatingsIntel. The company was upgraded on Wednesday, September 14 by Wolfe Research. The rating was maintained by Guggenheim on Tuesday, January 2 with “Hold”. On Tuesday, December 26 the stock rating was maintained by SunTrust with “Buy”. The firm has “Hold” rating by Jefferies given on Wednesday, August 10. On Monday, July 18 the stock rating was maintained by Barclays Capital with “Equalweight”. The company was maintained on Sunday, August 20 by RBC Capital Markets. On Wednesday, October 18 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. Jefferies downgraded PPL Corporation (NYSE:PPL) on Thursday, July 14 to “Hold” rating. On Monday, October 19 the stock rating was downgraded by Goldman Sachs to “Neutral”. The company was maintained on Tuesday, September 5 by Jefferies.

Since August 21, 2017, it had 0 insider buys, and 8 selling transactions for $1.90 million activity. WHEELER CRAIG A also sold $301,050 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares. Stoner Elizabeth sold $292,752 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) on Tuesday, January 30. Another trade for 802 shares valued at $12,190 was made by Leicher Bruce on Monday, August 21. Kaundinya Ganesh Venkataraman sold 821 shares worth $12,479.

Investors sentiment decreased to 1.73 in 2017 Q3. Its down 0.25, from 1.98 in 2017Q2. It dived, as 16 investors sold MNTA shares while 29 reduced holdings. 16 funds opened positions while 62 raised stakes. 70.23 million shares or 2.61% more from 68.45 million shares in 2017Q2 were reported. Aperio Gp Limited Liability holds 17,840 shares. Moreover, South Dakota Invest Council has 0.1% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Rhumbline Advisers invested 0.01% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Dimensional Fund Advisors LP owns 704,031 shares for 0.01% of their portfolio. Manufacturers Life Ins Communications The accumulated 56,008 shares or 0% of the stock. Dekabank Deutsche Girozentrale invested in 0% or 38,800 shares. Moreover, Arizona State Retirement Systems has 0.01% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) for 39,534 shares. Fmr Ltd holds 11.43M shares. Pictet Asset Management Limited holds 0.01% or 141,029 shares in its portfolio. Ubs Asset Americas holds 0% or 28,496 shares. New York State Common Retirement Fund reported 0.01% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Palo Alto Invsts Limited Company invested 1.4% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Acadian Asset Limited Liability Company holds 530,197 shares or 0.04% of its portfolio. Reilly Financial Limited Liability Company has invested 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). D E Shaw And Company accumulated 0.04% or 1.47M shares.

Among 12 analysts covering Momenta Pharmaceuticals (NASDAQ:MNTA), 4 have Buy rating, 2 Sell and 6 Hold. Therefore 33% are positive. Momenta Pharmaceuticals had 28 analyst reports since August 6, 2015 according to SRatingsIntel. Maxim Group downgraded it to “Sell” rating and $6 target in Wednesday, September 7 report. The firm earned “Hold” rating on Thursday, October 5 by Stifel Nicolaus. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, August 2. The company was upgraded on Friday, January 8 by Maxim Group. The company was upgraded on Tuesday, October 11 by Barclays Capital. On Wednesday, October 4 the stock rating was maintained by Barclays Capital with “Equal-Weight”. The firm has “Hold” rating given on Tuesday, November 22 by Aegis Capital. Goldman Sachs downgraded Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) rating on Thursday, August 6. Goldman Sachs has “Neutral” rating and $27 target. JP Morgan initiated Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) rating on Friday, November 13. JP Morgan has “Overweight” rating and $26 target. The firm has “Mkt Perform” rating given on Wednesday, February 22 by Leerink Swann.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: